RxDoctor Payments Data

Joseph Allen, MD

Family Medicine · Bowling Green, KYNPI 1316945314

Payments from drug & device makers

$6,111in general payments, 2019–2025

Across 479 payments — averaging $12.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • AbbVie$808
  • Corium, LLC$393
  • Amgen$358
  • Lilly USA, LLC$314
  • AstraZeneca$277
  • plus $3K from 45 others

What the payments were for

  • Food & beverage$6,07399%
  • Education$381%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,111 in reported general payments places this provider in the 85th percentile of 1,559 family medicine providers in Kentucky.

See all family medicine providers in Kentucky

Medicare billing

Part B allowed, 2024
$206,486
Medicare patients
707
Services billed
23,537

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin150$150,259
EliquisApixaban195$144,123
TrulicityDulaglutide44$85,996
JanuviaSitagliptin Phosphate64$81,868
MounjaroTirzepatide58$62,360
OtezlaApremilast13$62,309
RybelsusSemaglutide49$59,123
TradjentaLinagliptin75$49,052
Tresiba Flextouch U-200Insulin Degludec20$48,505
Trelegy ElliptaFluticasone/Umeclidin/Vilanter62$48,482
XareltoRivaroxaban37$48,241
OzempicSemaglutide39$47,691
FarxigaDapagliflozin Propanediol46$47,118
LinzessLinaclotide73$46,249
EntrestoSacubitril/Valsartan30$28,676

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta$160$199,311225 claims
PfizerEliquis, Premarin, Paxlovid$241$159,145264 claims
Lilly USA, LLCTrulicity, Mounjaro$314$148,356102 claims
MerckJanuvia, Janumet Xr, Janumet$145$133,204101 claims
Novo NordiskRybelsus, Ozempic$1,038$106,81488 claims
Johnson & JohnsonXarelto, Invokana$13$69,39857 claims
AstraZenecaFarxiga, Brilinta, Symbicort$277$66,48494 claims
GSKTrelegy Ellipta, Breo Ellipta$143$63,90094 claims
AmgenOtezla$358$62,30913 claims
AbbVieLinzess, Synthroid$808$50,689198 claims
Astellas Pharma US IncMyrbetriq$79$17,09317 claims
Sanofi-aventis U.S. LLCLantus$26$4,29718 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,559 family medicine providers in Kentucky.

Other family medicine in Bowling Green

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →